Spain ' s Grifols gives new details on past EBITDA, leverage ratios to supervisor

Spanish drugmaker Grifols on Thursday issued new details of its 2022 and 2023 accounts, including higher leverage ratios than previously reported based on a different calculation of its core earnings and debt, after it was required to do so by market supervisor CNMV. The new calculation is based…#spanish #grifols #cnmv #gothamcityresearch #gothamcity
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Health | Spain Health